U.S. Iron Supplement Market Expected to Reach $3,105.73 Million by 2032

According to a new report published by Allied Market Research, titled, “U.S. Iron Supplement Market by Form and Distribution Channel: Opportunity Analysis and Industry Forecast, 2023–2032", the U.S. iron supplement market was valued at $1,747.37 million in 2022, and is projected to reach $3,105.73 million by 2032, registering a CAGR of 5.9% from 2023 to 2032.

Iron supplements are preparations available in various dosage forms containing elemental iron to address iron deficiency in the body. Iron plays a crucial role in the production of hemoglobin, a protein that carries oxygen in the blood. The iron supplements become essential for individuals who don't obtain enough iron from their diet or suffer from iron deficiency anemia. Iron supplements are available in various dosage form such as tablets, capsules, gummies, and liquid. Oral iron supplements come in different forms, such as ferrous sulfate, ferrous gluconate, and ferrous fumarate. They are generally safe and effective, but excessive intake can lead to toxicity and adverse effects.

The increase in need for iron supplements due to various medical conditions is expected to drive the growth of the market. Anemia in pregnant women and infants has been a significant driver for the U.S. iron supplement market. Anemia is particularly prevalent in pregnant women and infants due to their unique physiological demands and growth requirements. According to 2023 Fact Sheet for Health Professionals by National Library of Medicine, it was reported that population in the U.S. usually obtain adequate amounts of iron from their diets, but infants, young children, teenaged girls, pregnant women, and premenopausal women are at risk of obtaining insufficient amounts. Pregnant women experience a higher demand for iron to support the growth and development of the fetus and to increase their own blood volume. Without adequate iron intake, pregnant women can develop iron-deficiency anemia, which may lead to adverse outcomes for both the mother and the child.

Moreover, according to 2022 report by American Society of Hematology, it was estimated that iron deficiency anemia (IDA) in pregnancy is common in the U.S., with an overall prevalence of 18%. Furthermore, in 2023 Fact Sheet for Health Professionals by National Library of Medicine, women of reproductive age who have menorrhagia, or abnormally heavy bleeding during menstruation, are at increased risk of iron deficiency. At least 10% of menstruating women are believed to have menorrhagia.

In addition, frequent blood donors have an increased risk of iron deficiency. In the U.S., adults donate blood as often as every 8 weeks, which can lead to iron deficiency. According to 2023 Fact Sheet for Health Professionals by National Library of Medicine, it was estimated that about 25%–35% of regular blood donors develop iron deficiency. Thus, iron deficiency among the frequent blood donors is expected to drive the growth for the U.S. iron supplement market.

Furthermore, the anemia in chronic diseases is also expected to drive the growth of the market. The relationship between chronic diseases and anemia is significant as many chronic conditions can lead to the disruption of the body's normal production or function of red blood cells. According to 2023 report by Centers of Disease Control and Prevention, it was estimated that 14% of people in the U.S. have chronic kidney disease (CKD).

The preferred treatment for anemia due to chronic kidney disease involves the use of erythropoiesis-stimulating agents along with iron supplementation. Thus, the increase in prevalence of iron deficiency anemia due to various factors, such as chronic kidney disease and chemotherapy induced anemia, is expected to drive the growth of the U.S. iron supplement market. In addition, the growing demand for dietary supplements in the U.S. propels the growth of the market. According to Council for Responsible Nutrition (CRN) consumer survey on dietary supplement, in 2019, it was reported that around 77% of Americans consume dietary supplements. As per the same source, it was also reported that approximately 81% of dietary supplements are consumed by adults between the age group of 35 years to 54 years. However, the side effects associated with iron supplements act as a restraint for the growth of the U.S. iron supplement market. On the basis of form, the market is categorized into solid, liquid, and others. The others include suppositories, and gaseous. The solid segment dominated the U.S. market in 2022. This is attributed to high adoption of oral iron supplements among consumers. However, the liquid form of iron supplements is expected to register fastest growth, owing to the high patient compliance especially in children and elderly patients.

By distribution channel, the market is divided into online and offline. The offline channels include retail pharmacies, hospital pharmacies, and others. The others include supermarkets and nutritional store. The offline segment dominated the global market in 2022 due to easily availability of iron supplements in offline channels such as retail stores, supermarkets, and hospital pharmacy. However, the online channel of distribution is expected to register fastest growth during the forecast period owing to the adoption of iron supplements through e-commerce platform, and easy accessibility of iron supplements at low cost.

Key Findings of the Study

• Based on form, the solid segment held the largest market share in 2022. However, the liquid segment is expected to register the fastest growth during the forecast period.
• On the basis of distribution channel, the offline segment held the largest market share in 2022. However, the online segment is expected to register the fastest growth during the forecast period.